Xie‐Yu Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xie‐Yu Fan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Can Liu
Hunan Provincial Key Laboratory of Xiangnan Rare‐Precious Metals Compounds Research and Applications, School of Chemistry and Environmental Science Xiangnan University Chenzhou Hunan Province China
1 shared publication - Chen‐Xuan Tang
Hunan Provincial Key Laboratory of Xiangnan Rare‐Precious Metals Compounds Research and Applications, School of Chemistry and Environmental Science Xiangnan University Chenzhou Hunan Province China
1 shared publication - Chuan‐Hua Li
Hunan Provincial Key Laboratory of Xiangnan Rare‐Precious Metals Compounds Research and Applications, School of Chemistry and Environmental Science Xiangnan University Chenzhou Hunan Province China
1 shared publication - Fei‐Hong Yao
Hunan Provincial Key Laboratory of Xiangnan Rare‐Precious Metals Compounds Research and Applications, School of Chemistry and Environmental Science Xiangnan University Chenzhou Hunan Province China
1 shared publication - Li‐Ming Tao
Hunan Provincial Key Laboratory of Xiangnan Rare‐Precious Metals Compounds Research and Applications, School of Chemistry and Environmental Science Xiangnan University Chenzhou Hunan Province China
1 shared publication - Tian‐Hong Deng
Hunan Provincial Key Laboratory of Xiangnan Rare‐Precious Metals Compounds Research and Applications, School of Chemistry and Environmental Science Xiangnan University Chenzhou Hunan Province China
1 shared publication
Latest Publications
- 10 December 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (1)
Synthesis, Crystal Structure, Formation Mechanism, Theoretical Studies, and Biological Evaluation of Azine‐Based Bismuth (III) Complex
The azine‐based bismuth (III) complex [Bi(H2L1)(NO3)3(H2O)2]•H2O(1a) was synthesized by an equivalent reaction between Schiff base and Bi (NO3)3•5H2O using mannitol as an auxiliary agent. During the formation of the complex (1a), the Schiff base containing 3‐methoxy group transformed into 3‐methoxysalicylaldehyde azine and further coordinated with BiIII ion to form a mononuclear BiIII complex (1a). Bismuth (III) ions were unexpectedly found to catalyze the formation of the azines from Schiff bases derived from pyrazinohydrazide, and their formation mechanism was further studied. Theoretical studies of the complex (1a) involving thermodynamic and electronic properties were done using the density functional theory (DFT) B3LYP method. Furthermore, in vitro biological evaluation showed that the antimicrobial and cytotoxic activities of the complex (1a) were much higher than those of free ligands. The obtained MIC and IC50 values of the complex (1a) were almost close to those of the reference drugs.
- 10 December 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (1)
Synthesis, Crystal Structure, Formation Mechanism, Theoretical Studies, and Biological Evaluation of Azine‐Based Bismuth (III) Complex
The azine‐based bismuth (III) complex [Bi(H2L1)(NO3)3(H2O)2]•H2O(1a) was synthesized by an equivalent reaction between Schiff base and Bi (NO3)3•5H2O using mannitol as an auxiliary agent. During the formation of the complex (1a), the Schiff base containing 3‐methoxy group transformed into 3‐methoxysalicylaldehyde azine and further coordinated with BiIII ion to form a mononuclear BiIII complex (1a). Bismuth (III) ions were unexpectedly found to catalyze the formation of the azines from Schiff bases derived from pyrazinohydrazide, and their formation mechanism was further studied. Theoretical studies of the complex (1a) involving thermodynamic and electronic properties were done using the density functional theory (DFT) B3LYP method. Furthermore, in vitro biological evaluation showed that the antimicrobial and cytotoxic activities of the complex (1a) were much higher than those of free ligands. The obtained MIC and IC50 values of the complex (1a) were almost close to those of the reference drugs.